NCT07682831Recruiting
Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Machine Learning Analysis of Expanded Two-photon Imaging of Skin Biopsy Specimens
Source: ClinicalTrials.gov · Last updated 19 Aug 2026
Brief summary (registry, in English)
The goal of this study is to investigate the ability of a machine learning model to evaluate two-photon fluorescence microscopy images of dermatologic biopsies at point of care. The main question it aims to answer is: • How well do two-photon fluorescence images of biopsies taken in a clinic and evaluated by a machine learning model agree with conventional histology?
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- First submitted
- 25 Jun 2026
- Start date
- 24 Jun 2026
- Primary completion date
- 1 Jun 2027
- Lead sponsor
- University of Rochester
- Diseases
- Childhood cancers
- NCT number
- NCT07682831
What you commit to
- Study type: Interventional
- Planned participants: 92
- From 24 Jun 2026 to the primary completion date, 1 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Biopsy indication includes melanoma or dysplastic/atypical nevus
- Excision thickness of less than 1 mm
- Excision longest dimension less than 2 mm
- Excision performed as multiple pieces in a single specimen container
Who the study is looking for
- Punch, excisional or shave biopsy specimen
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rochester Dermatologic Surgery Coordinator of this site? Confirm its status | Victor | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.